Ways of modernization of chronic kidney disease classification


Дәйексөз келтіру

Толық мәтін

Аннотация

Problems of chronic kidney disease classification optimization with albuminuria stge indexation is discussed

Әдебиет тізімі

  1. National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification. Am. J. Kidney. Dis. 2002;39 [Suppl 1]: S1-S266.
  2. Смирнов А.В., Есаян А.М., Каюков И.Г. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6(4): 11-17.
  3. Glassock R.J., Winearls C. The global burden of chronic kidney disease: How valid are the estimates? Nephron. Clin. Pract. 2008;110: 39-47
  4. Glassock R.J., Winearls C. Screening for CKD with eGFR: Doubts and dangers. Clin J Am Soc Nephrol 2008;3: 1563-1569.
  5. Glassock R.J., Winearls C. An epidemic of chronic kidney disease: Fact or fiction? Nephrol. Dial. Transplant. 2008; 23:1117-1121.
  6. Bauer C., Melamed M.L., Hostetter T.H. Staging of chronic kidney disease: Time for a course of correction. J Am Soc Nephrol 2008;19:844-846.
  7. Landray M.J., Haynes R.J. Commentary: Controversies in NICE guidance on chronic kidney disease. BMJ. 2008;337: a1793.
  8. Смирнов А.В., Добронравов В.А., Каюков И.Г., Есаян А.М. Хроническая болезнь почек: дальнейшее развитие концепции и классификации. Нефрология. 2007; 11(4): 7-17.
  9. Смирнов А.В,, Добронравов В.А., Каюков И.Г. Кардио-ренальный континуум: патогенетические основы превентивной нефрологии. Нефрология. 2005;9(3): 7-15.
  10. Majunath G., Tighionart H., Ibrahim H. et al. Level of kidney function as a risk factors for atherosclerotic cardiovascular outcomes in the community. J. Am. Coll. Cardiol. 2003; 41: 47- 55.
  11. Henry R.M., Kostense P.J., Bos G. et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int. 2002; 62: 1402- 1407.
  12. Nitsch D., Dietrich D.F., von Eckardstein A. et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephro.l Dial. Transplant. 2006; 21(4): 935-944.
  13. Segura J., Campo C., Ruilope L.M. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int. 2004; [Suppl 92]:S45-9.2004
  14. Mann J.F.E. Cardiovascular risk in patients with mild renal insufficiency: implication for the use of ACE inhibitors. La Presse Medicale. 2005; 34(18): 1303-1308.
  15. Myllymдki J., Syrjдnen J., Helin H <http://www.ncbi.nlm.nih.gov/pubmed/16522659?ordinalpos=2&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum>. et al.Vascular diseases and their risk factors in IgA nephropathy. Nephrol. Dial. Transplant. 2006; 21(7):1876-1882.
  16. Vanholder R., Massy Z., Argiles A., Spasovski G., Verbeke F., Lameire N.; European Uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. <http://www.ncbi.nlm.nih.gov/pubmed/15814534> Nephrol Dial Transplant 2005; 20(6):1048-1056.
  17. Смирнов А.В., Седов В.М., Лхаахуу Од-Эрдэнэ. и др. Снижение скорости клубочковой фильтрации как независимый фактор риска сердечно-сосудистой болезни. Нефрологи.я 2006; 10(4): 7-17.
  18. Мухин Н.А., Моисеев В.С., Кобалава Ж.Д. и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек. Тер арх. 2004; (6):39-46.
  19. Wen C.P., Cheng T.Y., Tsai M.K. et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008; 371(9631):2173-2182.
  20. Couser W.G.. Chronic kidney disease-The promise and the perils. J Am Soc Nephrol 2007; 18:2803-2805.
  21. Bauer C., Melamed ML, Hostetter TH Staging of chronic kidney disease: time for a course correction. J. Am. Soc. Nephrol. 2008:19 844-846.
  22. Glassock R.J., Winearls C. CKD-fiction not fact. Nephrol. Dial. Transplant. 2008;23:2695-2696.
  23. de Jong P.E., Gansevoort R.T.. Fact or fiction of the epidemic of chronic kidney disease-let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol. Dial. Transplant. 2008;23:1092-1095.
  24. Poggio E.D., Rule A.D. Can we do better than single estimated GFR threshold when screening for chronic kidney disease?. Kidney Int. 2007;72:534-536.
  25. Schmieder RE Schrader J, Zidek W et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007; 96(5):247-257;
  26. Klausen K.P. Scharling H., Jensen G., Jensen J.S. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension. 2005;46(1):33-37.
  27. Glassock R.J., Winearls C. Routine reporting of estimated glomerular filtration rate: Not ready for prime time. Nat. Clin. Pract. Nephrol. 2008; (8):422-423.
  28. Di Angelantonio E., Danesh J., Eiriksdottir G., Gudnason V.. Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review. PLoS Med. 2007. doi: 10.1371/journal.pmed.0040270.
  29. Shlipak M.G., Sarnak M.J., Katz R. et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N. Engl. J. Med. 2005; 352: 2049-2060.
  30. Wannamethee S.G., Shaper A.G., Lowe G.D.O. et al. Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J 2006;27:2975-2981.
  31. Ford I <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ford%20I%22%5BAuthor%5D>., Bezlyak V <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bezlyak%20V%22%5BAuthor%5D>., Stott D.J <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Stott%20DJ%22%5BAuthor%5D>. et al.Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med <javascript:AL_get(this,%20'jour',%20'PLoS%20%0d%0aMed.');> 2009;6(1): e16.
  32. Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. <http://www.ncbi.nlm.nih.gov/pubmed/15385656> N. Engl. J. Med. 2004;351(13):1296-305.
  33. Brantsma A.H., Bakker S.J., Hillege H.L., de Zeeuw D., de Jong P.E., Gansevoort R.T.; PREVEND Study Group.Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. <http://www.ncbi.nlm.nih.gov/pubmed/18641082> Nephrol. Dial. Transplan.t 2008; 23(12):3851-3858.
  34. de Jong P.E., van der Velde M., Gansevoort R.T., Zoccali C. Screening for chronic kidney disease: where does Europe go? <http://www.ncbi.nlm.nih.gov/pubmed/18287253> Clin. J. Am. Soc. Nephrol. 2008;3(2):616-623.
  35. Hallan S.I., Ritz E., Lydersen S. et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. <http://www.ncbi.nlm.nih.gov/pubmed/19357254> J Am Soc Nephrol 2009 20(5):1069-1077
  36. Rutkowski M <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rutkowski%20M%22%5BAuthor%5D>., Mann W <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Mann%20W%22%5BAuthor%5D>., Derose S <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Derose%20S%22%5BAuthor%5D>. et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am. J. Kidney. Dis <javascript:AL_get(this,%20'jour',%20'Am%20J%20Kidney%20Dis.');>. 2009;53 (3) [Suppl 3]:S86-99.
  37. Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States. <http://www.ncbi.nlm.nih.gov/pubmed/17986697> JAMA 2007; 298(17):2038-2047.
  38. Levey A.S., Bosch J.P., Lewis J.B. A more accurate method to estimate glomerular filtration rate from serum creatinine; a new prediction equation. Ann. Intern. Med. 1999;.130(8): 461-470.
  39. Froissart M., Rossert J., Jacquot C., Paillard M., Houillier P.. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. <http://www.ncbi.nlm.nih.gov/pubmed/15659562> J. Am. Soc. Nephrol. 2005;16(3):763-773.
  40. Foley R.N., Wang C., Snyder J.J., Collins A.J. Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES. <http://www.ncbi.nlm.nih.gov/pubmed/19339409> Clin. J. Am. Soc. Nephrol. 2009; 4(5):965-972.
  41. Botev R., Mallié J.P., Couchoud C. et al. Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. <http://www.ncbi.nlm.nih.gov/pubmed/19406960> Clin. J. Am. So.c Nephrol. 2009 4(5):899-906.
  42. Ma Y.C., Zuo L., Chen J.H. et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. <http://www.ncbi.nlm.nih.gov/pubmed/16988059> J. Am. Soc. Nephrol. 2006;17(10):2937-2944.
  43. Rule A.D., Larson T.S., Bergstralh E.J. et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. <http://www.ncbi.nlm.nih.gov/pubmed/15611490> Ann. Intern. Med. 2004;141(12):929-937.
  44. Horio M., Imai E., Yasuda Y., Watanabe T., Matsuo S. Modification of the CKD Epidemiology Collaboration (CKD-EPI) Equation for Japanese: Accuracy and Use for Population Estimates. <http://www.ncbi.nlm.nih.gov/pubmed/20416999> Am. J. Kidney. Dis. 2010 (in press).
  45. Glassock R.J., Winearls C. CKD in the elderly. Am. J. Kidney. Dis. 2008; 52:803
  46. Eknoyan G. Kidney disease: Wherefore, whence and whereto? Kidney Int. 2007; 71: 473-475.
  47. Levey A.S., Eckardt K.U., Tsukamoto Y. et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6): 2089-20100.
  48. Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Рекомендации Научно-исследовательского института нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова: определение, классификация, диагностика и основные направления профилактики хронической болезни почек у взрослых. СПб, Левша"; 51

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>